Author:
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Qiu X, Audet J, Wong G, Fernando L, Bello A, Pillet S, Alimonti JB, Kobinger GP, 2013. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci Rep 3: 3365.
-
2.
U.S. Food and Drug Administration, Expanded Access (Compassionate Use), 2015. Available at: http://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/ucm431774.htm. Accessed March 22, 2015.
-
3.
Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, Kraft CS, Towner JS, Spiropoulou C, Ströher U, Uyeki TM, Ribner BS, 2014. Emory serious communicable diseases unit. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 371: 2402–2409.
-
4.
WHO, 2014. Ethical Considerations for Use of Unregistered Interventions for Ebola Virus Disease (EVD). Summary of the Panel Discussion. Available at: http://www.who.int/mediacentre/news/statements/2014/ebola-ethical-review-summary/en/.
-
5.
Pollack A, 2014. Opting against Ebola Drug for Ill African Doctor. New York Times. Available at: http://www.nytimes.com/2014/08/13/world/africa/ebola.html?_r=1.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 10 | 10 | 3 |
| Full Text Views | 201 | 51 | 0 |
| PDF Downloads | 29 | 3 | 0 |
When Potentially Lifesaving Drugs are Both Experimental and in Very Short Supply: A Clinician's Story from the Front Lines of the Battle Against Ebola
Linda M. Mobula
Linda M. Mobula
Technical, Leadership and Research Division, Office of HIV/AIDS, United States Agency for International Development, Arlington, Virginia; Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland
Search for other papers by Linda M. Mobula in
Current site
Google Scholar
PubMed
Search for other papers by Linda M. Mobula in
Current site
Google Scholar
PubMed
Author Notes
Author's address: Linda M. Mobula, Technical, Leadership and Research Division, Office of HIV/AIDS, United States Agency for International Development, Arlington, VA, Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, E-mail: mmobula@usaid.gov.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Qiu X, Audet J, Wong G, Fernando L, Bello A, Pillet S, Alimonti JB, Kobinger GP, 2013. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci Rep 3: 3365.
-
2.
U.S. Food and Drug Administration, Expanded Access (Compassionate Use), 2015. Available at: http://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/ucm431774.htm. Accessed March 22, 2015.
-
3.
Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, Kraft CS, Towner JS, Spiropoulou C, Ströher U, Uyeki TM, Ribner BS, 2014. Emory serious communicable diseases unit. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 371: 2402–2409.
-
4.
WHO, 2014. Ethical Considerations for Use of Unregistered Interventions for Ebola Virus Disease (EVD). Summary of the Panel Discussion. Available at: http://www.who.int/mediacentre/news/statements/2014/ebola-ethical-review-summary/en/.
-
5.
Pollack A, 2014. Opting against Ebola Drug for Ill African Doctor. New York Times. Available at: http://www.nytimes.com/2014/08/13/world/africa/ebola.html?_r=1.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 10 | 10 | 3 |
| Full Text Views | 201 | 51 | 0 |
| PDF Downloads | 29 | 3 | 0 |